Literature Review on Provision of Appropriate and Accessible ...

PAGE 42
almost 18 per cent used Depot Medroxyprogesterone Acetate (DMPA).
[14]
The researchers <strong>Literature</strong> found <strong>Review</strong> that institutional Provision of factors Appropriate played and a major Accessible role
Support to People with an Intellectual Disability who are
in contraception usage amongst women with intellectual disability,
Experiencing Crisis Pregnancy
factors such as whether the women were residing in an institution or
at home with their parents, as well as the sexual relationship policy
and contraception policy of the institution. The following factors were
associated with an increased probability of using contraception:
• Residing in an institution
• Living in an institution where contraception is required or advised
• Living in an institution where sexual intercourse is not prohibited
• Having a milder disability.
Servais et al. (2002) comment on the low influence of personal or
medical factors in the women’s use of contraception and argued that
medical factors should be given more consideration when decisions
about contraception are being made. They assert that contraception
for sub-groups of women with intellectual disability should be more
comprehensively managed, taking into account medical factors
and the heterogeneity amongst women with intellectual disability.
Contraceptive choices, they argue, should not be exclusively influenced
by environmental factors.
Other findings from Servais et al.’s research included:
• Previous sexual intercourse and involvement in an affective
relationship were strongly associated with the level of disability.
• Women with severe intellectual disability had increased usage of
Depot Medroxyprogesterone Acetate.
14 The authors note that these figures differed widely from the general Belgian
population. Women with ID were using contraception less frequently (60% versus
68%), their contraceptive method was less likely to be an oral contraceptive agent
(18% versus 46%), and more often sterilisation (22% versus 7%) or DMPA (17%
versus ‹2%) (Servais et al., 2002).